Creative Planning Purchases 435 Shares of AMETEK, Inc. (NYSE:AME)
Creative Planning lifted its position in shares of AMETEK, Inc. (NYSE:AME) by 1.8% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 24,042 shares of the technology company’s stock after buying an additional 435 shares during the quarter. Creative Planning’s holdings in AMETEK were worth $2,208,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently bought and sold shares of the company. NumerixS Investment Technologies Inc bought a new stake in AMETEK during the second quarter valued at about $27,000. Shine Investment Advisory Services Inc. boosted its position in AMETEK by 67.8% during the third quarter. Shine Investment Advisory Services Inc. now owns 302 shares of the technology company’s stock valued at $28,000 after purchasing an additional 122 shares in the last quarter. Capital Bank & Trust Co bought a new stake in AMETEK during the second quarter valued at about $29,000. Berman Capital Advisors LLC boosted its position in AMETEK by 51.3% during the second quarter. Berman Capital Advisors LLC now owns 454 shares of the technology company’s stock valued at $41,000 after purchasing an additional 154 shares in the last quarter. Finally, Ibex Wealth Advisors bought a new stake in AMETEK during the second quarter valued at about $52,000. 86.51% of the stock is currently owned by institutional investors and hedge funds.
In other news, Director Elizebeth R. Varet sold 4,000 shares of the firm’s stock in a transaction dated Thursday, August 29th. The stock was sold at an average price of $85.69, for a total value of $342,760.00. Following the completion of the transaction, the director now directly owns 95,670 shares in the company, valued at $8,197,962.30. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Elizebeth R. Varet sold 3,000 shares of the firm’s stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $96.20, for a total value of $288,600.00. Following the completion of the transaction, the director now owns 90,670 shares of the company’s stock, valued at $8,722,454. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 38,560 shares of company stock valued at $3,659,482. Company insiders own 0.80% of the company’s stock.
Shares of NYSE AME opened at $96.54 on Friday. The company has a debt-to-equity ratio of 0.46, a quick ratio of 1.48 and a current ratio of 2.05. The company has a market cap of $22.00 billion, a PE ratio of 29.34, a P/E/G ratio of 2.13 and a beta of 1.20. The business has a 50-day simple moving average of $90.22 and a two-hundred day simple moving average of $87.83. AMETEK, Inc. has a fifty-two week low of $63.14 and a fifty-two week high of $97.30.
AMETEK (NYSE:AME) last announced its quarterly earnings data on Thursday, October 31st. The technology company reported $1.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.01 by $0.05. AMETEK had a return on equity of 20.04% and a net margin of 16.63%. The firm had revenue of $1.28 billion during the quarter, compared to analysts’ expectations of $1.28 billion. During the same period last year, the business posted $0.91 earnings per share. The company’s revenue for the quarter was up 7.0% compared to the same quarter last year. On average, sell-side analysts predict that AMETEK, Inc. will post 4.14 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 20th. Stockholders of record on Friday, December 6th will be paid a $0.14 dividend. This represents a $0.56 annualized dividend and a dividend yield of 0.58%. AMETEK’s payout ratio is 17.02%.
AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices worldwide. The company's Electronic Instruments segment offers advanced instruments for the process, aerospace, power, and industrial markets; process control instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; and instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets.
Further Reading: How to Trade Using Analysts Ratings
Want to see what other hedge funds are holding AME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AMETEK, Inc. (NYSE:AME).
Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.